A detailed history of Jacobson & Schmitt Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Jacobson & Schmitt Advisors, LLC holds 2,691 shares of JNJ stock, worth $417,131. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,691
Previous 2,731 1.46%
Holding current value
$417,131
Previous $399,000 9.27%
% of portfolio
0.09%
Previous 0.09%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$145.48 - $167.38 $5,819 - $6,695
-40 Reduced 1.46%
2,691 $436,000
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $394,301 - $430,897
2,731 New
2,731 $399,000
Q4 2023

Feb 08, 2024

SELL
$145.6 - $158.88 $72,800 - $79,440
-500 Reduced 15.67%
2,691 $421,000
Q3 2023

Nov 07, 2023

SELL
$155.75 - $174.48 $36,912 - $41,351
-237 Reduced 6.91%
3,191 $496,000
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $16,615 - $19,828
-110 Reduced 3.11%
3,428 $531,000
Q2 2022

Aug 08, 2022

SELL
$168.19 - $186.01 $28,592 - $31,621
-170 Reduced 4.58%
3,538 $628,000
Q1 2022

May 06, 2022

BUY
$158.14 - $179.59 $170,791 - $193,957
1,080 Added 41.1%
3,708 $657,000
Q4 2021

Feb 10, 2022

BUY
$155.93 - $173.01 $409,784 - $454,670
2,628 New
2,628 $450,000
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $209,627 - $232,952
-1,298 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$159.48 - $171.07 $10,366 - $11,119
65 Added 5.27%
1,298 $214,000
Q1 2021

May 11, 2021

BUY
$153.07 - $170.48 $188,735 - $210,201
1,233 New
1,233 $203,000
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $298,843 - $351,199
-2,458 Closed
0 $0
Q1 2018

Jul 27, 2018

BUY
$125.1 - $148.14 $153,873 - $182,212
1,230 Added 100.16%
2,458 $315,000
Q1 2018

May 08, 2018

SELL
$125.1 - $148.14 $153,873 - $182,212
-1,230 Reduced 50.04%
1,228 $157,000
Q2 2017

Aug 10, 2017

BUY
N/A
2,458
2,458 $325,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Jacobson & Schmitt Advisors, LLC Portfolio

Follow Jacobson & Schmitt Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobson & Schmitt Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobson & Schmitt Advisors, LLC with notifications on news.